A report on the current projects of the MetrioPharm team
Timetables on the office
walls, e-mails with long to-do lists and meetings of all project groups: The
new year has started off busy. In order to move the MetrioPharm pipeline ahead
as planned, the team is coordinating several major projects simultaneously.
One of the most important is the completion of the Phase II trial in the indication psoriasis...
In spring 2018, we met the three founders of MetrioPharm AG in Zurich for an interview. We talked about the right intuition for molecules with potential, about the ongoing clinical trial and MetrioPharm’s plans for the future
In 2007, the three of you founded MetrioPharm AG together. How did this happen?
In our last blog entry, our CEO Dr. Wolfgang Brysch replied to the question: “Does MetrioPharm have competition? You can find the full article here. In this article we take a closer look at a drug that has already been tested.
If a patient suffers from an autoimmune disease, for example psoriasis, his physician ...